Dicerna Pharmaceuticals reported -0.22 in EPS Earnings Per Share for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Acceleron Pharma XLRN:US -1.16 0.11
Agenus AGEN:US 0.69 1.06
Alnylam Pharmaceuticals ALNY:US $ -1.64 0.03
Amgen AMGN:US $ 4.67 0.29
Arrowhead Research ARWR:US -0.61 0.32
Biogen BIIB:US $ 4.77 0.91
Bluebird Bio BLUE:US $ -3.16 0.27
Dicerna Pharmaceuticals DRNA:US -0.22 0.31
Exelixis EXEL:US 0.12 0.18
Gilead Sciences GILD:US $ 2.65 0.78
GlaxoSmithKline GSK:LN 0.37 0.08
Immunogen IMGN:US -0.18 0.03
Intercept Pharmaceuticals ICPT:US $ -0.63 0.3
Intrexon XON:US $ -0.15 0.05
IONIS PHARMACEUT IONS:US $ -0.58 0.01
Karyopharm Therapeutics KPTI:US -0.69 0.02
Lexicon Pharmaceuticals LXRX:US -0.16 0.03
Macrogenics MGNX:US -0.86 0.2
Merk MRK:US $ 1.75 0.44
Mirati Therapeutics MRTX:US -1.55 1.68
Pfizer PFE:US $ 1.34 0.27
Regeneron Pharmaceuticals REGN:US $ 14.37 11.43
Regulus Therapeutics RGLS:US -0.1 0.02
Ultragenyx Pharmaceutical RARE:US $ -1.08 0.73